City

London (1)

Singapore (1)

Condition

Haloperidol (2)

Advanced Cancer (1)

Hyperactive Delirium (1)

L-DOPA (1)

Olanzapine (1)

Placebo (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 3 (1)

Sponsor

King's College London (1)

Tan Tock Seng Hospital (1)

Collaborator

Medical Research Council (1)

Intervention

haldol 2mg/ml oral solution (1)

haloperidol (1)

l-dopa (1)

olanzapine actavis 5mg orodispersible tablet (1)

placebo - cap (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

haloperidol

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Haloperidol, Advanced Cancer, Hyperactive Delirium Trial in Singapore (Haldol 2mg/ml oral solution, Olanzapine Actavis 5mg

Recruiting

Haloperidol
+3 more

Haldol 2mg/ml oral solution
Olanzapine Actavis 5mg orodispersible tablet

Singapore, Singapore
+2 more

May 6, 2022

Haloperidol, Placebo, L-DOPA Trial in London (Placebo - Cap, L-dopa, Haloperidol)

Completed

Haloperidol
+2 more

Placebo - Cap
+2 more

London, United Kingdom

Centre for Neuroimaging Sciences

Oct 9, 2019